International Clinical Trial: Real-world Comparison of Second-line Treatments for Lung Cancer Patients Progressed After Initial Immunotherapy

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128702) titled 'Real-world Comparison of Second-line Treatments for Lung Cancer Patients Progressed After Initial Immunotherapy' on July 24.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The Fourth Affiliated Hospital, Zhejiang University School of Medicine

Condition: Advanced Non-Small Cell Lung Cancer (AJCC Stage IIIB-IV)

Intervention: Single chemotherapy regimen:None Chemotherapy combined with continuous original ICI:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Single chemotherapy regimen:100;Chemotherapy combined with co...